
Beyond the Price Tag: What Generic Drug Tariffs Could Mean for Patients’ Access to Medication
Editor’s Note: Patient Worthy is honored to share this article, originally written by Renzo Luzzatti, President and CEO of US-Rx Care. The White House recently





















